2023-10-06T16:10:51-05:00 2022-12-31 390859910 BAKER TILLY US LLP 66 HUDSON BLVD E SUITE 2200 NEW YORK NY 10001 990 2022-01-01 061559393 GLOBAL LYME ALLIANCE INC GLOB 2039691333 1290 EAST MAIN ST 3RD FLOOR STAMFORD CT 06902 LAURA MACNEILL CEO 2039691333 2023-10-05 1 LAURA MACNEILL XXX-XX-XXXX 0 PATRICK YU CPA P00675982 2126976900 2023-10-05 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z LAURA MACNEILL 1290 EAST MAIN ST 3RD FLOOR STAMFORD CT 06902 3254675 0 X GLOBALLYMEALLIANCE.ORG X 1999 CT GLOBAL LYME ALLIANCE FUNDS RESEARCH, EDUCATION & AWARENESS FOR LYME & TICK-BORNE DISEASES. 28 28 9 430 0 0 2734537 2975690 60525 93925 1206 33630 -167073 -248536 2629195 2854709 1350820 872859 0 0 927362 934019 0 0 451214 1279032 914989 3557214 2721867 -928019 132842 4008676 3843093 844323 719053 3164353 3124040 X GLOBAL LYME ALLIANCE IS THE LEADING NONPROFIT DEDICATED TO CONQUERING LYME AND OTHER TICK-BORNE DISEASES. OUR MISSION: CURE LYME AND OTHER TICK-BORNE DISEASES THROUGH INNOVATIVE RESEARCH, AWARENESS, AND EMPOWERING THE PATIENT VOICE. 0 0 1018168 0 93925 GLOBAL LYME ALLIANCE (GLA) HAS A STRONG TRACK RECORD OF PROGRAM SERVICE ACCOMPLISHMENTS IN THREE MAJOR AREAS, MEASURED BY EXPENSES: RESEARCH ADVANCEMENTS: GLA INVESTS IN RESEARCH, DRIVING SIGNIFICANT PROGRESS IN LYME AND TICK-BORNE DISEASE STUDIES. THEIR CONTRIBUTIONS INCLUDE GROUNDBREAKING WORK IN DIAGNOSTICS, TREATMENT, AND UNDERSTANDING OF LYME BACTERIA. NOTABLE ACHIEVEMENTS COMPRISE CHARACTERIZING CHRONIC LYME DISEASE, GENOME SEQUENCING OF BORRELIA BURGDORFERI STRAINS, UNCOVERING ANTIBIOTIC RESISTANCE MECHANISMS, AND DOCUMENTING IMMUNE DYSFUNCTION IN PATIENTS. RECENT DISCOVERIES INCLUDE THE ROLE OF CELL WALL-DEFICIENT FORMS (L-FORMS) IN CHRONIC INFECTIONS, POTENTIALLY AIDING EARLY LYME DISEASE CURE.PATIENT SUPPORT: GLA IS COMMITTED TO AIDING PATIENTS, CAREGIVERS, AND LOVED ONES AFFECTED BY THESE DISEASES. THEY OFFER VARIOUS SUPPORT PROGRAMS, SUCH AS ACCESS TO SPECIALISTS, FINANCIAL ASSISTANCE INFORMATION, CLINICAL TRIAL OPPORTUNITIES, EMOTIONAL SUPPORT MENTORSHIP, AND EDUCATIONAL MATERIALS. THEIR HOLISTIC APPROACH ADDRESSES PATIENTS AND FAMILIES' CHALLENGES COMPREHENSIVELY.KNOWLEDGE AND AWARENESS: GLA'S RESEARCH AND EDUCATIONAL INITIATIVES HAVE PLAYED A PIVOTAL ROLE IN ENHANCING UNDERSTANDING AND AWARENESS OF LYME AND TICK-BORNE DISEASES. THEIR FUNDING OF STUDIES CONNECTING LYME DISEASE TO PSYCHIATRIC DISORDERS HAS BROADENED AWARENESS OF THE DISEASES' IMPACT ON PATIENTS' WELL-BEING. MOREOVER, GLA'S DEDICATION TO SHARING EDUCATIONAL RESOURCES AND CLINICAL TRIAL INFORMATION EMPOWERS THE COMMUNITY TO MAKE INFORMED HEALTH DECISIONS. 872859 872859 0 GLOBAL LYME ALLIANCE CONTINUES TO ADVANCE THE RESEARCH AND SCIENCE FOR LYME AND OTHER TICK-BORNE DISEASES THROUGH ITS ROBUST RESEARCH GRANT PROGRAM. GLA'S SCIENTIFIC ADVISORY BOARD (SAB), COMPRISED OF DISTINGUISHED RESEARCHERS IN MULTIDISCIPLINARY FIELDS IN LYME AND TICK-BORNE DISEASE, PROVIDES STRATEGIC GUIDANCE TO GLOBAL LYME ALLIANCE IN ITS REVIEW AND AWARD PROCESS TO ADVANCE RESEARCH AT LEADING INSTITUTIONS WITH A GOAL OF IMPROVING DIAGNOSTICS AND TREATMENT OF LYME AND OTHER TICK-BORNE ILLNESSES.AS THE LEADING PATIENT VOICE LYME NON-PROFIT MEASURED BY OUR AUDIENCE SHARE, GLA GETS INPUT FROM OUR MEDICAL ADVISORY BOARD AND PATIENT ADVOCATES TO DRIVE RESEARCH DISCOVERY; GLA BRIDGES THE GAP BETWEEN PATIENT AND RESEARCH TO INFORM WHERE SCIENCE NEEDS TO GO TO FIND A CURE. 1891027 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 31 0 9 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 28 28 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 AL AR CA FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OR PA RI SC TN UT VA WI WV X X X JENNIFER KATRITOS FINANCE DIRECTOR 2039691333 1290 EAST MAIN ST 3RD FLOOR STAMFORD CT 06902 PAUL ROSS CHAIRMAN 10.00 0.00 X X 0 0 0 JANET VACCARO SECRETARY 4.00 0.00 X X 0 0 0 HENRY DOSCH TREASURER 15.00 0.00 X X 0 0 0 DEBORAH SICILIANO VICE CHAIR 20.00 0.00 X X 0 0 0 DIANE BLANCHARD VICE CHAIR 20.00 0.00 X X 0 0 0 ROBERT KOBRE DIRECTOR 20.00 0.00 X 0 0 0 NANCY DEL GENIO DIRECTOR 40.00 0.00 X 0 0 0 DAVID NOLAN DIRECTOR 2.00 0.00 X 0 0 0 EDWARD O'CONNELL DIRECTOR 2.00 0.00 X 0 0 0 KAREN PEETZ DIRECTOR 2.00 0.00 X 0 0 0 DANA MCAVITY DIRECTOR 2.00 0.00 X 0 0 0 BRETT KRISTOFF DIRECTOR 2.00 0.00 X 0 0 0 LORRIE NADEL DIRECTOR 2.00 0.00 X 0 0 0 RIDGWAY BARKER DIRECTOR 2.00 0.00 X 0 0 0 CHRIS CORRINET DIRECTOR 2.00 0.00 X 0 0 0 DAVID GERSTNER DIRECTOR 2.00 0.00 X 0 0 0 JULIA KNOX-COMEAU DIRECTOR 2.00 0.00 X 0 0 0 STEVE LEFKOWITZ DIRECTOR 2.00 0.00 X 0 0 0 LEWIS LEONE DIRECTOR 2.00 0.00 X 0 0 0 STEVEN MARTIN DIRECTOR 2.00 0.00 X 0 0 0 PETER NORLEY DIRECTOR TO NOVEMBER 2022 2.00 0.00 X 0 0 0 NORMA RUSSO DIRECTOR 2.00 0.00 X 0 0 0 ALEXANDER TISCH DIRECTOR 2.00 0.00 X 0 0 0 ERIN WALKER DIRECTOR 2.00 0.00 X 0 0 0 AZIZ SYRIANI DIRECTOR 2.00 0.00 X 0 0 0 BRENT PATRY DIRECTOR 2.00 0.00 X 0 0 0 KAREN KELLY DIRECTOR 2.00 0.00 X 0 0 0 CHARLES BALDUCCI DIRECTOR 2.00 0.00 X 0 0 0 ROSE ANASTASIO DIRECTOR 2.00 0.00 X 0 0 0 AVRIL LAVIGNE DIRECTOR TO FEBRUARY 2022 2.00 0.00 X 0 0 0 SCOTT MORESCO DIRECTOR TO NOVEMBER 2022 2.00 0.00 X 0 0 0 LAURA MACNEILL CHIEF EXECUTIVE OFFICER 40.00 0.00 X 113850 0 0 TIMOTHY SELLATI CHIEF SCIENTIFIC OFFICER 40.00 0.00 X 237500 0 9746 351350 0 9746 2 0 1 0 0 1618846 1356844 15429 2975690 FEE FOR SERVICE 541700 93925 93925 93925 33630 33630 151430 1618846 399966 -248536 -248536 2854709 93925 0 -214906 X 872859 872859 364815 247697 117118 476035 270604 121916 83515 26499 13113 9748 3638 66670 41335 9334 16001 54906 54906 283264 37921 122700 122643 87029 22391 15957 48681 116994 72536 16379 28079 13633 8110 3703 1820 16040 16040 4200 4200 53774 33340 7528 12906 11556 7165 1618 2773 AWARENESS 214663 202187 12476 CLINICAL STUDIES/OTHER 45046 45046 LICENSE FEES & PERMITS 10326 10326 MISCELLANEOUS EXPENSE 2157 1157 1000 1401 683 154 564 2721867 1891027 379626 451214 388799 852688 2855434 2346964 213575 60000 10275 7518 200000 81645 65606 351265 321887 83152 29378 334616 156616 41180 124323 4008676 3843093 121185 69848 699574 552500 23564 96705 844323 719053 X 2293587 2458077 870766 665963 3164353 3124040 4008676 3843093 X 132842 -173155 X 0 1 X 1 0 X 4889010 5180006 2861182 2734537 2975690 18640425 4889010 5180006 2861182 2734537 2975690 18640425 1212207 17428218 39469 49812 13537 1206 33630 137654 268205 169804 151430 589439 19367518 154450 0.89990 0.91260 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING INCOME - 2018 AMOUNT: $ 268,205. 2019 AMOUNT: $ 169,804. 2022 AMOUNT: $ 151,430. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 63178 59659 3519 288087 262228 25859 29378 OPERATING LEASE LIABILITY 96705 96705 X 2715215 38506 -178000 -139494 2854709 0 2854709 2760373 38506 38506 2721867 0 2721867 PART X, LINE 2: MANAGEMENT HAS EVALUATED GLA'S TAX POSITIONS AND CONCLUDED THAT GLA HAD NOT TAKEN ANY UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD ("FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") NO. 740. PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON INVESTMENT IN THIRD PARTY -178,000. GLA GLOBAL GALA 1533440 1440314 93126 182475 142225 GOLF OUTING 206244 168188 38056 47167 1 10360 10344 16 16 1750044 1618846 131198 229642 142225 16 371883 -240685 1 YALE UNIVERSITY 25 SCIENCE PARK 150 MUNSON STREET NEW HAVEN CT 065208327 060646973 501(C)(3) 150000 0 RESEARCH THE UNIVERSITY OF CENTRAL FLORIDA PO BOX 160118 ORLANDO FL 328160118 592924021 501(C)(3) 175000 0 RESEARCH VIRGINIA POLYTECHNIC INSTITUTE 300 TURNER STREET NW SUITE 4200MC 0170 BLACKSBURG VA 24061 506001805 501(C)(3) 175000 0 RESEARCH UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 500 SOUTH LIMESTONE 109 KINKEAD HALL LEXINGTON KY 405260001 616033693 501(C)(3) 215000 0 RESEARCH EMBLEMATIC GROUP INC 12417 STANWOOD PLACE LOS ANGELES CA 90066 10000 0 MARKETING THE CHILDREN'S HOSPITAL CORPORATION BOSTON CHILDREN'S HOSPITAL PO BOX 414413 BOSTON MA 02241 042774441 501(C)(3) 175000 0 RESEARCH 5 1 PART I, LINE 2: THE ORGANIZATION REQUIRES PROGRESS UPDATES FROM THE RECIPIENTS IN ACCORDANCE WITH THE WRITTEN GRANT AGREEMENTS THAT ARE SIGNED BY THE RECIPIENTS. PART II THE AMOUNT OF GRANTS PER SCHEDULE I IS HIGHER THAN WHAT IS REPORTED ON PART IX, LINE 1 DUE TO GRANT FUNDS OF $27,141 WERE RETURNED PER TERMINATION AGREEMENT FROM THE TRUSTEES OF COLUMBIA UNIVERSITY. X X X X 0 0 0 0 0 0 0 1 0 TIMOTHY SELLATI CHIEF SCIENTIFIC OFFICER 225000 0 12500 0 0 0 0 0 9746 0 247246 0 0 0 PART I, LINE 7 EXECUTIVE TEAM'S BONUSES ARE BASED ON MEETING GOALS AND OBJECTIVE AS DETERMINED BY THE BOARD, HR COMMITTEE WITH APPROVAL OF THE EC OF THE BOARD AT THE BEGINNING OF EACH YEAR. THE AMOUNT OF THE BONUS IS BASED ON RECOMMENDATION FROM THE HR COMMITTEE AND APPROVED BY THE BOD. X 2 15429 NYSE 0 0 1 0 PART I, COLUMN (B): THE NUMBER ON PART I, COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY BOTH MANAGEMENT AND THE FINANCE COMMITTEE. THE FORM 990 IS THEN DISTRIBUTED TO THE FULL BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTERESTS ARE AFFIRMED ANNUALLY IN WRITING. FURTHERMORE, A DIRECTOR OR OFFICER SHALL DISCLOSE A CONFLICT OF INTEREST (A) PRIOR TO VOTING ON OR OTHERWISE DISCHARGING HIS/HER DUTIES WITH RESPECT TO ANY MATTER INVOLVING THE CONFLICT WHICH COMES BEFORE THE BOARD OR ANY COMMITTEE; (B) PRIOR TO ENTERING INTO ANY CONTRACT OR TRANSACTION INVOLVING THE CONFLICT; AND (C) AS SOON AS POSSIBLE AFTER THE DIRECTOR OR OFFICER LEARNS OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S EXECUTIVE COMMITTEE DETERMINES COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND/OR OTHER OFFICERS AND KEY EMPLOYEES BY DOING RESEARCH IN THE MARKETPLACE FOR COMPARABLE POSITIONS. THE BOARD OF DIRECTORS APPROVES COMPENSATION FOR EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AT GLA.ORG AND UPON REQUEST. PART VI, SECTION A, LINE 1(A) THE BOARD OF DIRECTORS HAS DELEGATED BROAD AUTHORITY TO THE EXECUTIVE COMMITTEE TO RUN THE DAILY OPERATIONS OF THE ORGANIZATION. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 37,921. MANAGEMENT AND GENERAL EXPENSES 122,700. FUNDRAISING EXPENSES 122,643. TOTAL EXPENSES 283,264. FORM 990, PART XI, LINE 9: IMPAIRMENT LOSS ON INVESTMENT -178,000. LEASE ACCOUNTING ADOPTION ADJUSTMENT 4,845.